| Filed | Form | Description | |
|---|---|---|---|
| 3/10/25 | DEFA14A | DEFA14A | → |
| 2/26/25 | DEF 14A | DEF 14A | → |
| 2/14/25 | PRE 14A | PRE 14A | → |
| 8/4/23 | DEF 14A | DEF 14A | → |
| 7/24/23 | PRE 14A | PRE 14A | → |
| 1/25/23 | DEFR14A | DEFR14A | → |
| ↓ | |||
| Filed | Form | Description | |
|---|---|---|---|
| 2/14/24 | SC 13G | SC 13G | → |
| 2/14/24 | SC 13G/A | SC 13G/A | → |
| 2/13/24 | SC 13G/A | SC 13G/A | → |
| 2/13/24 | SC 13G/A | SC 13G/A | → |
| 2/12/24 | SC 13G/A | SC 13G/A | → |
| 2/9/24 | SC 13G/A | OCEAN BIOMEDICAL INC 13GA | → |
| ↓ | |||
Ocean Biomedical is a new-generation American biopharmaceutical company based in Providence, Rhode Island. The company has product candidates addressing malaria, pulmonary fibrosis, and lung cancer.